Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» In latest setback, another Coherus partner bails out on Amgen biosimilar deal
In latest setback, another Coherus partner bails out on Amgen biosimilar deal
In latest setback, another Coherus partner bails out on Amgen biosimilar deal
Submitted by
admin
on July 5, 2017 - 9:37am
Source:
Endpoints
News Tags:
Coherus
Amgen
biosimilars
Daiichi Sankyo
CHS-0214
rheumatoid arthritis
Enbrel
Headline:
In latest setback, another Coherus partner bails out on Amgen biosimilar deal
Do Not Allow Advertisers to Use My Personal information
